Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats
Authors:
- 30 April 1993
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 32 (4) , 373-376
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha‐bungarotoxin‐treated rats.The Journal of Physiology, 1992
- A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junctionEuropean Journal of Pharmacology, 1991
- Controversies about the treatment of myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Immunology of acetylcholine receptors in relation to myasthenia gravis.Physiological Reviews, 1980
- Ephedrine: A postsynaptic depressant drug at the mammalian neuromuscular junctionNeuropharmacology, 1979
- Acetylcholine in Intercostal Muscle from Myasthenia Gravis Patients and in Rat Diaphragm after Blockade of Acetylcholine Receptors1979
- Theophylline compounds end myasthenia gravis; I. In vitro studiesClinical Pharmacology & Therapeutics, 1973
- THE DIAGNOSIS AND TREATMENT OF MYASTHENIA GRAVISJAMA, 1939
- A REPORT OF PROGRESS ON THE USE OF EPHEDRINE IN A CASE OF MYASTHENIA GRAVISJAMA, 1930